214 related articles for article (PubMed ID: 19558726)
1. Effect of Fuzheng Huayu formula and its actions against liver fibrosis.
Liu C; Hu Y; Xu L; Liu C; Liu P
Chin Med; 2009 Jun; 4():12. PubMed ID: 19558726
[TBL] [Abstract][Full Text] [Related]
2. The effect and mechanisms of Fuzheng Huayu formula against chronic liver diseases.
Chen J; Hu Y; Chen L; Liu W; Mu Y; Liu P
Biomed Pharmacother; 2019 Jun; 114():108846. PubMed ID: 30965233
[TBL] [Abstract][Full Text] [Related]
3. Progress in clinical and basic research of fuzheng Huayu formula for the treatment of liver fibrosis.
Zhou X; Fu Y; Chen J; Liu P
J Ethnopharmacol; 2024 Jun; 327():118018. PubMed ID: 38453100
[TBL] [Abstract][Full Text] [Related]
4. Active Components Formulation Developed from Fuzheng Huayu Recipe for Anti-Liver Fibrosis.
Sun X; Tan Y; Lyu J; Liu HL; Zhao ZM; Liu CH
Chin J Integr Med; 2022 Jun; 28(6):538-544. PubMed ID: 34581939
[TBL] [Abstract][Full Text] [Related]
5. Investigation of the absorbed and metabolized components of Danshen from Fuzheng Huayu recipe and study on the anti-hepatic fibrosis effects of these components.
Yang T; Shen DP; Wang QL; Tao YY; Liu CH
J Ethnopharmacol; 2013 Jul; 148(2):691-700. PubMed ID: 23707207
[TBL] [Abstract][Full Text] [Related]
6. The Novel Chinese Medicine JY5 Formula Alleviates Hepatic Fibrosis by Inhibiting the Notch Signaling Pathway.
Fu Y; Xiao Z; Tian X; Liu W; Xu Z; Yang T; Hu Y; Zhou X; Fang J; Gao S; Zhang D; Mu Y; Zhang H; Hu Y; Huang C; Chen J; Liu P
Front Pharmacol; 2021; 12():671152. PubMed ID: 34630075
[TBL] [Abstract][Full Text] [Related]
7. Dynamical Regulation Analysis Identifies Molecular Mechanisms of Fuzheng-Huayu Formula against Hepatitis B-Caused Liver Cirrhosis.
Chen QL; Lu YY; Peng JH; Dong S; Wei B; Song YN; Zhou QM; Zhang H; Liu P; Su SB
Evid Based Complement Alternat Med; 2015; 2015():238495. PubMed ID: 26221171
[TBL] [Abstract][Full Text] [Related]
8. Fuzheng Huayu recipe alleviates liver fibrosis via inhibiting NLRP3 inflammasome activation in macrophages.
Ping D; Qi J; Li M; Sun X; Peng Y; Liu C
J Ethnopharmacol; 2024 Jan; 318(Pt B):117001. PubMed ID: 37544346
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of a Botanical Formula Fuzheng Huayu for Hepatic Fibrosis in Patients with CHC: Results of a Phase 2 Clinical Trial.
Hassanein T; Tai D; Liu C; Box TD; Tong MJ; Rossaro L; Pozza R; Glenn JS; Cheung R; Hemaidan A; He Y; Behling C; Hu X; Makhlouf H; Fan H; Ren Y; Khim Chng EL; Liu P; Vierling JM
Evid Based Complement Alternat Med; 2022; 2022():4494099. PubMed ID: 35873630
[TBL] [Abstract][Full Text] [Related]
10. Fuzheng Huayu recipe alleviates hepatic fibrosis via inhibiting TNF-α induced hepatocyte apoptosis.
Tao YY; Yan XC; Zhou T; Shen L; Liu ZL; Liu CH
BMC Complement Altern Med; 2014 Nov; 14():449. PubMed ID: 25407538
[TBL] [Abstract][Full Text] [Related]
11. Fuzheng Huayu Recipe Ameliorates Liver Fibrosis by Restoring Balance between Epithelial-to-Mesenchymal Transition and Mesenchymal-to-Epithelial Transition in Hepatic Stellate Cells.
Pan Q; Wang YQ; Li GM; Duan XY; Fan JG
Biomed Res Int; 2015; 2015():935903. PubMed ID: 26881209
[TBL] [Abstract][Full Text] [Related]
12. Metabolic mechanisms of Fuzheng-Huayu formula against liver fibrosis in rats.
Hu XQ; Song YN; Wu R; Cai FF; Zhang Y; Peng JH; Hu YY; Su SB
J Ethnopharmacol; 2019 Jun; 238():111888. PubMed ID: 31004725
[TBL] [Abstract][Full Text] [Related]
13. Advances in anti hepatic fibrotic therapy with Traditional Chinese Medicine herbal formula.
Li H
J Ethnopharmacol; 2020 Apr; 251():112442. PubMed ID: 31891799
[TBL] [Abstract][Full Text] [Related]
14. The components data of fuzheng huayu extracts,
Liu W; Li Z; Sun Z; Xu Y; Wang S; Hu Y; Peng J
Data Brief; 2019 Aug; 25():104087. PubMed ID: 31294053
[TBL] [Abstract][Full Text] [Related]
15. Active Compounds Derived from Fuzheng Huayu Formula Protect Hepatic Parenchymal Cells from Apoptosis Based on Network Pharmacology and Transcriptomic Analysis.
Wu R; Dong S; Cai FF; Chen XL; Yang MD; Liu P; Su SB
Molecules; 2019 Jan; 24(2):. PubMed ID: 30669350
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological mechanisms of Fuzheng Huayu formula for Aristolochic acid I-induced kidney fibrosis through network pharmacology.
Wang F; Wang S; Wang J; Huang K; Chen G; Peng Y; Liu C; Tao Y
Front Pharmacol; 2022; 13():1056865. PubMed ID: 36569327
[TBL] [Abstract][Full Text] [Related]
17. Fuzheng Huayu Recipe and its active compounds inhibited HBeAg production by promoting TOMM34 gene expression in HBV-infected hepatocytes.
Xing L; Zeng R; Huang K; Xue J; Liu H; Zhao Z; Peng Y; Hu X; Liu C
Front Pharmacol; 2022; 13():907921. PubMed ID: 36249820
[No Abstract] [Full Text] [Related]
18. [Action mechanism and active components of Fuzheng Huayu Recipe against liver fibrosis via regulating macrophage with network pharmacology and transcriptomics methods].
Xing L; Hu XD; Tao YY; Peng Y; Liu CH
Zhongguo Zhong Yao Za Zhi; 2022 Jun; 47(11):3029-3037. PubMed ID: 35718527
[TBL] [Abstract][Full Text] [Related]
19. The Active Components of Fuzheng Huayu Formula and Their Potential Mechanism of Action in Inhibiting the Hepatic Stellate Cells Viability - A Network Pharmacology and Transcriptomics Approach.
Xing X; Chen S; Li L; Cao Y; Chen L; Wang X; Zhu Z
Front Pharmacol; 2018; 9():525. PubMed ID: 29881350
[No Abstract] [Full Text] [Related]
20. Fuzheng Huayu inhibits carbon tetrachloride-induced liver fibrosis in mice through activating hepatic NK cells.
Cheng Q; Li N; Chen M; Zheng J; Qian Z; Wang X; Huang C; Li Q; Lin Q; Shi G
J Ethnopharmacol; 2013 Jan; 145(1):175-81. PubMed ID: 23127651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
